Presymptomatic biochemical changes in hindlimb muscle of G93A human Cu/Zn superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 7-8, 2008, Pages 462-468

  Park, Kevin H J ^a   Vincent, Inez ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

ALS; Amyotrophic lateral sclerosis; cdk5; Cyclin D1; Cyclin dependent kinase 5; G93A hSOD1; Muscle; MyoD; Presymptomatic; Transgenic mice

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIN D1; CYCLIN DEPENDENT KINASE 5; MUTANT PROTEIN; MYOD PROTEIN; CDK5 PROTEIN, MOUSE; CYCLIN D; CYCLINE; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN; SOD1 G93A PROTEIN; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; ENZYME ACTIVITY; HINDLIMB; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TRANSGENIC MOUSE; AMINO ACID SUBSTITUTION; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; INNERVATION; METABOLISM; MUTATION;

MUS; MUS MUSCULUS;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CYCLIN-DEPENDENT KINASE 5; CYCLINS; DISEASE MODELS, ANIMAL; HINDLIMB; HUMANS; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUTATION; MYOD PROTEIN; SUPEROXIDE DISMUTASE;

EID: 49649114155     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.04.001     Document Type: Article

References (51)

1. Deng H.-X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.-Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., Warner C., Deng G., Soriano E., Smyth C., Parge H.E., Ahmed A., Roses A.D., Hallewell R.A., Pericak-Vance M.A., and Siddique T. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261 (1993) 1047-1051
2. Mulder D.W., Kruland L.T., Offord K.P., and Beard C.M. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36 (1986)
3. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
4. Gurney M.E. Transgenic-mouse model of amyotrophic lateral sclerosis. N Engl J Med 331 (1994) 1721-1722
5. Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., and Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 689-693
6. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., and Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18 (1997) 327-338
7. Boillée S., Vande Velde C., and Cleveland D.W. ALS: a disease of motor neurons and their non-neuronal neighbors. Neuron 52 (2006) 39-59
8. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., Brown Jr. R.H., Julien J.P., Goldstein L.S., and Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302 (2003) 113-117
9. Boillée S., Yamanaka K., Lobsinger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., and Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312 (2006) 1389-1392
10. Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., and Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10 (2007) 615-622
11. Xiao Q., Zhao W., Beers D.R., Yen A.A., Xie W., Henkel J.S., and Appel S.H. Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia. J. Neurochem. 102 (2007) 2008-2019
12. Miller T.M., Kim S.H., Yamanaka K., Hester M., Umapathi P., Arnson H., Rizo L., Mendell J.R., Gage F.H., Cleveland D.W., and Kaspar B.K. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 19546-19551
13. Musarò A., Dobrowolny G., and Rosenthal N. The neuroprotective effects of a locally acting IGF-1 isoform. Exp. Gerontol. 42 (2007) 76-80
14. Chiu A.Y., Zhai P., Dal Canto M.C., Peters T.M., Kwon Y.W., Prattis S.M., and Gurney M.E. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6 (1995) 349-362
15. Pun S., Santos A.F., Saxena S., Xu L., and Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9 (2006) 408-419
16. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., and Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185 (2004) 232-240
17. Frey D., Schneider C., Xu L., Borg J., Spooren W., and Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20 (2000) 2534-2542
18. Kennel P.F., Finiels F., Revah F., and Mallet J. Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study. NeuroReport 7 (1996) 1427-1431
19. Schaefer A.M., Sanes J.R., and Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 490 (2005) 209-219
20. Gould T.W., Buss R.R., Vinsant S., Prevette D., Sun W., Knudson C.M., Milligan C.E., and Oppenheim R.W. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26 (2006) 8774-8786
21. Sharp P.S., Dick J.R., and Greensmith L. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience 130 (2005) 897-910
22. Dobrowolny G., Giacinti C., Pelosi L., Nicoletti C., Winn N., Barberi L., Molinaro M., Rosenthal N., and Musarò A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. JCB 168 (2005) 193-199
23. Li W., Brakefield D., Pan Y., Hunter D., Myckatyn T.M., and Parsadanian A. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp. Neurol. 203 (2007) 457-471
24. Kaspar B.K., Llado J., Sherkat N., Rothstein J.D., and Gage F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301 (2003) 839-842
25. Rabinovsky E.D., Gelir E., Gelir S., Lui H., Kattash M., DeMayo F.J., Shenaq S.M., and Schwartz R.J. Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. FASEB J. 17 (2003) 53-55
26. Musarò A., McCullagh K., Paul A., Houghton L., Dobrowolny G., Molinaro M., Barton E.R., Sweeney H.L., and Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27 (2001) 195-200
27. Holzbaur E.L., Howland D.S., Weber N., Wallace K., She Y., Kwak S., Tchistiakova L.A., Murphy E., Hinson J., Karim R., Tan X.Y., Kelley P., McGill K.C., Williams G., Hobbs C., Doherty P., Zaleska M.M., Pangalos M.N., and Walsh F.S. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol. Dis. 23 (2006) 697-707
28. Xie Z., Samuels B.A., and Tsai L.H. Cyclin-dependent kinase 5 permits efficient cytoskeletal remodeling-a hypothesis on neuronal migration. Cereb. Cortex 16 (2006) i64-i68
29. Cheung Z.H., Fu A.K., and Ip N.Y. Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases. Neuron 50 (2006) 13-18
30. Fu A.K., Fu W.Y., Cheung J., Tsim K.W., Ip F.C., Wang J.H., and Ip N.Y. Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat. Neurosci. 4 (2001) 374-381
31. Fu A.K., Ip F.C., Fu W.Y., Cheung J., Wang J.H., Yung W.H., and Ip N.Y. Aberrant motor axon projection, acetylcholine receptor clustering, and neurotransmission in cyclin-dependent kinase 5 null mice. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15224-15229
32. Lin W., Dominguez B., Yang J., Aryal P., Brandon E.P., Gage F.H., and Lee K.F. Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism. Neuron 46 (2005) 569-579
33. Lazaro J.-B., Kitzmann M., Poul M.-A., Vandromme M., Lamb N.J.C., and Fernandez A. Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J. Cell Sci. 110 (1997) 1251-1260
34. Philpott A., Porro E.B., Kirschner M.W., and Tsai L.H. The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev. 11 (1997) 1409-1421
35. Fu W.Y., Fu A.K., Lok K.C., Ip F.C., and Ip N.Y. Induction of Cdk5 activity in rat skeletal muscle after nerve injury. NeuroReport 13 (2002) 243-247
36. Hallows J.L., Chen K., DePinho R.A., and Vincent I. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. J. Neurosci. 23 (2003) 10633-10644
37. Bu B., Li J., Davies P., and Vincent I. Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci. 22 (2002) 6515-6525
38. Tsai L.H., Delalle I., Caviness Jr. V.S., Chae T., and Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371 (1994) 419-423
39. Luo S., Vacher C., Davies J.E., and Rubinsztein D.C. Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implication for mutant huntingtin toxicity. JCB 169 (2005) 647-656
40. Megeney L., and Rudnicki M.A. Determination versus differentiation and the MyoD family of transcription factors. Biochem. Cell. Biol. 73 (1995) 723-732
41. Perry R.L., and Rudnicki M.A. Molecular mechanisms regulating myogenic determination and differentiation. Front. Biosci. 5 (2000) D570-D767
42. Yablonka-Reuveni Z., Rudnicki M.A., Rivera A.J., Primig M., Anderson J.E., and Natanson P. The transition from proliferation to differentiation is delayed in satellite cells from mice lacking MyoD. Dev. Biol. 210 (1999) 440-455
43. Megeney L.A., Kablar B., Garrett K., Anderson J.E., and Rudnicki M.A. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10 (1996) 1173-1183
44. G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 28 (2007) 154-164
45. Koishi K., Zhang M., McLennan I.S., and Harris A.J. MyoD protein accumulates in satellite cells and is neurally regulated in regenerating myotubes and skeletal muscle fibers. Dev. Dyn. 202 (1995) 244-254
46. Ishido M., Kami K., and Masuhara M. In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle. Am. J. Physiol., Cell. Physiol. 287 (2004) C484-C493
47. Weis J., Jun, and Fos. MyoD1, and myogenin proteins are increased in skeletal muscle fiber nuclei after denervation. Acta Neuropathol. 87 (1994) 63-70
48. Yang W., Zhang Y., Li Y., Wu Z., and Zhu D. Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3b pathway and is antagonized by insulin-like growth factor 1. J. Biol. Chem. 282 (2007) 3799-3808
49. Siriett V., Salerno M.S., Berry C., Nicholas G., Bower R., Kambadur R., and Sharma M. Antagonism of myostatin enhances muscle regeneration during sarcopenia. Mol. Ther. 15 (2007) 1463-1470
50. Takahashi S., and Kulkarni A.B. Mutant superoxide dismutase 1 causes motor neuron degeneration independent of cyclin-dependent kinase 5 activation by p35 or p25. J. Neurochem. 88 (2004) 1295-1304
51. Turner B.J., Lopes E.C., and Cheema S.S. Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci. Lett. 350 (2003) 132-136